🇺🇸 FDA
Patent

US 11905327

Single-domain antibodies and variants thereof against TIGIT

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 11905327 (Single-domain antibodies and variants thereof against TIGIT) held by Nanjing Legend Biotech Co., Ltd expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nanjing Legend Biotech Co., Ltd
Grant date
Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2039/507, A61P, A61P35/00